The U.S. National Institutes of Health (NIH) has started a late-stage trial to evaluate if immune-modulating therapies from three drugmakers can help reduce the need for ventilators for COVID-19 ...
Swiss contract drug maker Lonza struck a deal with California-based biopharmaceutical company Humanigen to expand manufacturing capacity for Humanigen's lenzilumab, a drug candidate in late-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback